Drug class
Tetracyclic antidepressant; noradrenergic and specific serotonergic antidepressant (NaSSA-like pharmacology)
Mechanism of action
Antagonises presynaptic alpha-2 adrenergic autoreceptors and heteroreceptors, increasing noradrenergic and serotonergic neurotransmission. It also antagonises 5-HT2 and 5-HT3 receptors and has potent H1-histamine receptor antagonism that contributes to sedation.
General use cases
- Treatment of depressive illness in adults in countries where mianserin is authorised; product availability and current indications are jurisdiction-specific
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
